J.B. Chemicals & Pharmaceuticals Ltd - Shs Dematerialised

BOM:506943 (India)   Shs Dematerialised
₹ 1768.65 (+0.18%) May 29
47.48
P/B:
8.80
Market Cap:
₹ 274.50B ($ 3.29B)
Enterprise V:
₹ 273.54B ($ 3.28B)
Volume:
2.27K
Avg Vol (2M):
4.88K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for J.B. Chemicals & Pharmaceuticals Ltd ( ) from 1991 to May 30 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. J.B. Chemicals & Pharmaceuticals stock (BOM:506943) PE ratio as of May 30 2024 is 47.48. More Details

J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) PE Ratio (TTM) Chart

To

J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) PE Ratio (TTM) Historical Data

Total 1276
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
J.B. Chemicals & Pharmaceuticals PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-31 50.7 2024-03-20 48.6
2024-05-29 50.7 2024-03-19 48.5
2024-05-28 50.6 2024-03-18 49.3
2024-05-27 51.1 2024-03-14 47.5
2024-05-24 47.8 2024-03-13 47.6
2024-05-23 48.1 2024-03-12 48.5
2024-05-22 48.8 2024-03-11 48.1
2024-05-21 51.0 2024-03-07 48.7
2024-05-17 52.3 2024-03-06 48.6
2024-05-16 52.5 2024-03-05 48.1
2024-05-15 52.0 2024-03-04 48.0
2024-05-14 51.4 2024-03-01 47.0
2024-05-13 51.5 2024-02-29 47.7
2024-05-10 51.6 2024-02-28 49.2
2024-05-09 50.6 2024-02-27 50.4
2024-05-08 51.4 2024-02-26 50.5
2024-05-07 51.7 2024-02-23 50.4
2024-05-06 53.1 2024-02-22 50.9
2024-05-03 54.1 2024-02-21 51.3
2024-05-02 54.1 2024-02-20 50.5
2024-04-30 54.6 2024-02-19 50.7
2024-04-29 54.6 2024-02-16 50.6
2024-04-26 53.4 2024-02-15 50.9
2024-04-25 53.2 2024-02-14 51.4
2024-04-24 52.3 2024-02-13 50.8
2024-04-23 51.1 2024-02-12 51.5
2024-04-22 51.2 2024-02-09 52.8
2024-04-19 51.0 2024-02-08 54.0
2024-04-18 51.5 2024-02-07 54.8
2024-04-16 51.5 2024-02-06 52.8
2024-04-15 51.4 2024-02-05 52.2
2024-04-12 51.6 2024-02-02 51.7
2024-04-10 50.3 2024-02-01 51.6
2024-04-09 49.5 2024-01-31 51.5
2024-04-08 49.1 2024-01-30 50.6
2024-04-05 49.2 2024-01-29 51.9
2024-04-04 48.8 2024-01-25 51.8
2024-04-03 48.3 2024-01-24 51.8
2024-04-02 48.1 2024-01-23 50.8
2024-04-01 48.4 2024-01-19 49.5
2024-03-28 47.3 2024-01-18 48.7
2024-03-27 50.4 2024-01-17 50.3
2024-03-26 49.4 2024-01-16 50.9
2024-03-22 49.3 2024-01-15 50.8
2024-03-21 49.6 2024-01-12 51.5

J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.